 Chlorhexidine Dihydrochloride |
|||
| C157-5G | TOKU-E | 5 g | EUR 72.00 |
) Chlorhexidine (dihydrochloride) |
|||
| HY-B1145 | MEDCHEMEXPRESS | 100mg | EUR 119.00 |
 Chlorhexidine |
|||
| C156-1G | TOKU-E | 1 g | EUR 105.00 |
Chlorhexidine |
|||
| C156-5G | TOKU-E | 5 g | EUR 326.00 |
Chlorhexidine |
|||
| GP9341-1G | Glentham Life Sciences | 1 g | EUR 94.00 |
Chlorhexidine |
|||
| HY-B1248 | MEDCHEMEXPRESS | 100mg | EUR 119.00 |
 Chlorhexidine HCl |
|||
| abx187869-1kg | Abbexa | 1 kg | EUR 871.00 |
|
|||
Chlorhexidine HCl |
|||
| B1695-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108.00 |
|
Description: Chlorhexidine hydrochloride is an antiseptic effective against a wide variety of gram-negative and gram-positive organisms. |
|||
Chlorhexidine HCl |
|||
| B1695-50 | ApexBio | 50 mg | EUR 128.00 |
|
Description: Chlorhexidine hydrochloride is an antiseptic effective against a wide variety of gram-negative and gram-positive organisms. |
|||
 Chlorhexidine digluconate |
|||
| B3525-50 | ApexBio | 50 mg | EUR 128.00 |
) Chlorhexidine (digluconate) |
|||
| HY-B0608 | MEDCHEMEXPRESS | 5g | EUR 223.00 |
Chlorhexidine digluconate |
|||
| TBW00044 | ChemNorm | unit | Ask for price |
 Chlorhexidine diacetate salt |
|||
| C200-25G | TOKU-E | 25 g | EUR 180.00 |
 Chlorhexidine diacetate salt hydrate |
|||
| GA1676-100G | Glentham Life Sciences | 100 g | EUR 309.00 |
Chlorhexidine diacetate salt hydrate |
|||
| GA1676-1G | Glentham Life Sciences | 1 g | EUR 46.00 |
Chlorhexidine diacetate salt hydrate |
|||
| GA1676-25G | Glentham Life Sciences | 25 g | EUR 110.00 |
Chlorhexidine diacetate salt hydrate |
|||
| GA1676-5G | Glentham Life Sciences | 5 g | EUR 70.00 |
 Mizolastine dihydrochloride |
|||
| B1116-100 | ApexBio | 100 mg | EUR 238.00 |
|
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. |
|||
Mizolastine dihydrochloride |
|||
| B1116-200 | ApexBio | 200 mg | EUR 390.00 |
|
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. |
|||
Mizolastine dihydrochloride |
|||
| B1116-500 | ApexBio | 500 mg | EUR 653.00 |
|
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. |
|||
 Mibefradil dihydrochloride |
|||
| A3605-10 | ApexBio | 10 mg | EUR 263.00 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
Mibefradil dihydrochloride |
|||
| A3605-25 | ApexBio | 25 mg | EUR 553.00 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
Mibefradil dihydrochloride |
|||
| A3605-5 | ApexBio | 5 mg | EUR 168.00 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
Mibefradil dihydrochloride |
|||
| A3605-50 | ApexBio | 50 mg | EUR 996.00 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
|||
 Pramipexole dihydrochloride |
|||
| A3733-20 | ApexBio | 20 mg | EUR 108.00 |
|
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
|||
Pramipexole dihydrochloride |
|||
| A3733-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113.00 |
|
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
|||
Pramipexole dihydrochloride |
|||
| A3733-50 | ApexBio | 50 mg | EUR 131.00 |
|
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
|||
 Retigabine dihydrochloride |
|||
| A3758-10 | ApexBio | 10 mg | EUR 137.00 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
| A3758-100 | ApexBio | 100 mg | EUR 435.00 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
| A3758-5 | ApexBio | 5 mg | EUR 105.00 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
| A3758-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 142.00 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
| A3758-50 | ApexBio | 50 mg | EUR 271.00 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
 Veliparib dihydrochloride |
|||
| A3958-10 | ApexBio | 10 mg | EUR 148.00 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
| A3958-200 | ApexBio | 200 mg | EUR 835.00 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
| A3958-5 | ApexBio | 5 mg | EUR 125.00 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
| A3958-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 116.00 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
| A3958-50 | ApexBio | 50 mg | EUR 351.00 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
 AT7867 dihydrochloride |
|||
| A3199-10 | ApexBio | 10 mg | EUR 340.00 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
| A3199-100 | ApexBio | 100 mg | EUR 1842.00 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
| A3199-5 | ApexBio | 5 mg | EUR 267.00 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
| A3199-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 287.00 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
| A3199-50 | ApexBio | 50 mg | EUR 1281.00 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
 Canertinib dihydrochloride |
|||
| A3276-10 | ApexBio | 10 mg | EUR 108.00 |
|
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Canertinib dihydrochloride |
|||
| A3276-100 | ApexBio | 100 mg | EUR 189.00 |
|
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Canertinib dihydrochloride |
|||
| A3276-50 | ApexBio | 50 mg | EUR 148.00 |
|
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
 Inolitazone dihydrochloride |
|||
| A3499-5 | ApexBio | 5 mg | EUR 698.00 |
|
Description: Description:IC50 Value: 0.8 nM [1]Inolitazone(RS5444) is a novel high-affinity PPARgamma agonist, which activates PPARgamma with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARgamma. |
|||
 LDK378 dihydrochloride |
|||
| A3544-10 | ApexBio | 10 mg | EUR 155.00 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
| A3544-100 | ApexBio | 100 mg | EUR 276.00 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
| A3544-5 | ApexBio | 5 mg | EUR 125.00 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
| A3544-5.1 | ApexBio | 10 mM (in 1mL H2O) | EUR 154.00 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
LDK378 dihydrochloride |
|||
| A3544-50 | ApexBio | 50 mg | EUR 200.00 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
|||
 Alexidine dihydrochloride |
|||
| A4542-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108.00 |
|
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
|||
Alexidine dihydrochloride |
|||
| A4542-50 | ApexBio | 50 mg | EUR 184.00 |
|
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
|||
 GGACK Dihydrochloride |
|||
| A2582-5 | ApexBio | 5 mg | EUR 235.00 |
|
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
|||
 PPACK Dihydrochloride |
|||
| A2588-10 | ApexBio | 10 mg | EUR 353.00 |
|
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
|||
PPACK Dihydrochloride |
|||
| A2588-25 | ApexBio | 25 mg | EUR 757.00 |
|
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
|||
PPACK Dihydrochloride |
|||
| A2588-5 | ApexBio | 5 mg | EUR 221.00 |
|
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
|||
 Vatalanib Dihydrochloride |
|||
| 2025-25 | Biovision | EUR 305.00 | |
Vatalanib Dihydrochloride |
|||
| 2025-5 | Biovision | EUR 126.00 | |
 1400W dihydrochloride |
|||
| 2055-25 | Biovision | EUR 338.00 | |
1400W dihydrochloride |
|||
| 2055-5 | Biovision | EUR 126.00 | |
GGACK Dihydrochloride |
|||
| 1847-5 | Biovision | 5 mg | EUR 319.00 |
|
|||
|
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
|||
PPACK Dihydrochloride |
|||
| 1848-5 | Biovision | EUR 251.00 | |
 Puromycin Dihydrochloride |
|||
| 1860-100 | Biovision | EUR 272.00 | |
Puromycin Dihydrochloride |
|||
| 1860-1000 | Biovision | EUR 1295.00 | |
Puromycin Dihydrochloride |
|||
| 1860-25 | Biovision | EUR 126.00 | |
Puromycin Dihydrochloride |
|||
| 1860-250 | Biovision | EUR 457.00 | |
Puromycin Dihydrochloride |
|||
| 1860-500 | Biovision | EUR 805.00 | |
 Emetine dihydrochloride |
|||
| 1970-250 | Biovision | EUR 359.00 | |
Emetine dihydrochloride |
|||
| 1970-50 | Biovision | EUR 137.00 | |